Scientist sues Nobel assembly for awarding medicine prize to wrong people

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e8414 (Published 11 December 2012)
Cite this as: BMJ 2012;345:e8414

Recent rapid responses

Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on bmj.com. Although a selection of rapid responses will be included as edited readers' letters in the weekly print issue of the BMJ, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window.

Displaying 1-2 out of 2 published

Rongxiang Xu’s legal challenge to the Nobel Prize awarding body reminds us of many such disheartened scientists in history of Nobel Prizes. Going public with their feelings of angst is not new. Raymond Damadian,the patent holder for magnetic resonance imaging (MRI), expressed himself by putting out full page advertisements in The New York Times and other prominent newspapers (1). Claiming to be the original inventor of MRI, he thought that he should have shared the prize won by Paul Lauterbur and Peter Mansfield for the work on MRI. There are many such examples i.e. Lisa Meitner (discovered nuclear fission), Oswald Avery (discovered DNA in 1944), Jocelyn Bell Burnell (discovered the radio pulsar), Rosalind Franklin (showed DNA structure photographs to Crick) etc. but the protests are usually confined to and with in the scientific fraternity.

Winning a Nobel Prize is the index of global acceptance of any scientist’s work. Given the inherent extra-ordinariness of such prize winning studies, controversies are a possibility given the peer review systems that are never fool proof. The lack of scientific consensus in evaluating the merits of such extraordinary studies can be easily appreciated from the compilation of many such peer discrepancies by Juan Miguel Campanario(1).

Public protests & legal suits may not be the best platforms for scientists like Rongxiang Xu to communicate their point to seek justice. But, the recourse to arbitration in this manner, is a reflection on our community’s role as trustee of mechanisms that ensure due recognition of scientific merit. Our peer review systems, journal boards, scientific committees & organisations like Nobel Committee need to strengthen the systems further so as to avoid spillage of scientific discontent to public domains. It is more pertinent for award like Nobel, that can’t be awarded posthumous or be shared by more than a fixed number of people. By publishing this news BMJ has proven that the scientific journals should also be fulfilling the responsibility of being a ‘watch dogs’ and not just‘cheer leaders’ always(2).

References-
1. Coping with peer rejection. [No authors listed] Nature. 2003 Oct 16;425(6959):645
2. Cheerleader or watchdog? [No authors listed] Nature. 2009 Jun 25;459(7250):1033

Competing interests: None declared

Brij B. Agarwal, General Surgeon

Nayan Agarwal, Krishna A. Agarwal

Dr. Agarwal's Surgery and Sir Ganga Ram Hospital, India, F-81 & F-82, Street# 4, Virender Nagar, Janakpuri, New Delhi-110058, India

Click to like:

12 December 2012

Prizes are precious but precarious. Our birth is gratis, but then we pursue status, chasing the chalice, which all too often becomes a poisoned chalice.

Competing interests: None declared

Hugh Mann, Physician

Retired, Eagle Rock, MO, USA

Click to like:

THIS WEEK'S POLL